Skip to main content
SpringerLink
Log in

Dermatika und Wundbehandlungsmittel

  • Chapter
Arzneiverordnungs-Report 2001

  • 65 Accesses

Zusammenfassung

Dermatika zählen in Deutschland zu den verordnungsstärksten Arzneimitteln. Ihre Anwendungsgebiete sind sehr unterschiedlich. Entsprechend heterogen sind die Stoffklassen, die von wirkstofffreien Zubereitungen bis zu hochwirksamen Corticosteroidexterna reichen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Altmeyer P.J., Matthes U., Pawlak F., Hoffmann K., Frosch P.J., Ruppert P. et al. (1994): Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J. Am. Acad. Dermatol. 30: 977–981.

    Article  PubMed  CAS  Google Scholar 

  • Ammon H.P.T., Sabieraj J., Kaul R. (1996): Kamille. Mechanismus der antiphlogistischen Wirkung von Kamillenextrakten und -inhaltsstoffen. Dtsch. Apoth. Ztg. 136:1821–1834.

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (1999): Nutzen und Risiken durch Fumarsäure-Ester bei der Therapie der Psoriasis. Dtsch. Ärztebl. 96: A–721.

    Google Scholar 

  • Asadullah K., Schmid H., Friedrich M., Randow F., Volk H.-D., Sterry W., Döcke W.-D. (1997): Influence of monomethylfumarate on monocytic cytokine formation - explanation for adverse and therapeutic effects in psoriasis? Arch. Dermatol. Res. 289: 623–630.

    Article  PubMed  CAS  Google Scholar 

  • Ashcroft D.M., Li Wan Po A., Griffiths C.E.M. (2000): Therapeutic strategies for psoriasis. J. Clin. Pharm. Ther. 25:1–10.

    Article  PubMed  CAS  Google Scholar 

  • Bradley M., Cullum N., Sheldon T. (1999): The debridement of chronic wounds: a systematic review. Health Technol. Assess. 3:1–78.

    PubMed  CAS  Google Scholar 

  • Braun-Falco O., Plewig G., Wolff H.H. (1995): Dermatologie und Venerologie, 4. Aufl. Springer-Verlag, Berlin Heidelberg New York.

    Google Scholar 

  • Brogden R.N., Goa K.L. (1997): Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs 53:511–519.

    Article  PubMed  CAS  Google Scholar 

  • Bundesgesundheitsamt (1988): Monographie Fumarsäuremonoalkylester, Fumar-säuredialkylester, Fumarsäure und Fumarsäuresalze. Bundesanzeiger vom 11.10.1988, Nr. 191.

    Google Scholar 

  • Bundesgesundheitsamt (1993): Monographie Steinkohlenteer. Bundesanzeiger 45: 845.

    Google Scholar 

  • Bundesinstitut für Arzneimittel und Medizinprodukte (2001): Schreiben vom 1.6.2001.

    Google Scholar 

  • Byrne A., Hnatko G. (1995): Depression associated with isotretinoin therapy. Can. J. Psychiatry 40: 567.

    PubMed  CAS  Google Scholar 

  • Chaffman M.O. (1999): Topical corticosteroids: A review of properties and principles in therapeutic use. Nurse Practitioner Forum 10: 95–105.

    PubMed  CAS  Google Scholar 

  • Christiansen J.V., Gadborg E., Kleiter I., Ludvigsen K., Meier C.H., Norholm A. et al. (1977): Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial. Dermatologica 154:177–184.

    CAS  Google Scholar 

  • Daschner F. (1987): Sind Lokalantibiotika bei Hautinfektionen sinnvoll? Arzneiverordnung 4: 41–46.

    Google Scholar 

  • De Jong R., Bezemer A.C., Zomerdijk T.P.L., van de Pouw-Kraan T., Ottenhoff T.H.M., Nibbering P.H. (1996): Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur. J. Immunol. 26: 2067–2074.

    Article  PubMed  Google Scholar 

  • Feldman S. (2000): Advances in psoriasis treatment. Dermatol. Online J. 6:4.

    PubMed  CAS  Google Scholar 

  • Fine J.D., Johnson L. (1988): Evaluation of the efficacy of topical bufexamac in epidermolysis bullosa simplex. A double-blind placebo-controlled crossover trial. Arch. Dermatol. 124: 1669–1672.

    Article  PubMed  CAS  Google Scholar 

  • Fricke U., Klaus W. (1985): Die neuen Arzneimittel - Wirkungsweise und therapeutischer Stellenwert. Eine Übersicht von Januar 1983 - Juni 1984. Offizinpharmazie 10:1–71.

    Google Scholar 

  • Fricke U., Klaus W. (1991): Neue Arzneimittel 1990/91. Fortschritte für die Arzneimitteltherapie? Wissenschaftliche Verlagsgesellschaft, Stuttgart.

    Google Scholar 

  • Fricke U., Klaus W. (1992): Neue Arzneimittel 1991/92. Fortschritte für die Arzneimitteltherapie? Wissenschaftliche Verlagsgesellschaft, Stuttgart.

    Google Scholar 

  • Glass D., Boorman G.C., Stables G.I., Cunliffe W.J., Goode K. (1999): A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0,05%) and erythromycin (2%) with gels containing isotretinoin (0,05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris. Dermatology 199: 242–247.

    Article  PubMed  CAS  Google Scholar 

  • Gloor M. (1982): Pharmakologie dermatologischer Externa. Springer-Verlag, Berlin Heidelberg New York.

    Book  Google Scholar 

  • Gniazdowska B., Rueff F., Przybilla B. (1999): Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs. Contact Dermatitis 40: 63–65.

    Article  PubMed  CAS  Google Scholar 

  • Greaves M.W., Weinstein G.D. (1995): Treatment of psoriasis. N. Engl. J. Med. 332: 581–588.

    Article  PubMed  CAS  Google Scholar 

  • Griffiths C.E., Clark C.M., Chalmers R.J., Li Wan Po A., Williams H.C. (2000): A systematic review of treatments for severe psoriasis. Health Technol. Assess. 4: 1–125.

    PubMed  CAS  Google Scholar 

  • Hahn C, Röseler S., Fritzsche R., Schneider R., Merk H.F. (1993): Allergic contact reaction to dexpanthenol: lymphocyte transformation test and evidence for microsomal-dependent metabolism of the allergen. Contact Dermatitis 28: 81–83.

    Article  PubMed  Google Scholar 

  • Hölzle E. (1984): Therapie der Hyperhidrosis. Hautarzt 35: 7–15.

    Google Scholar 

  • Hornstein O.P., Nürnberg E. (Hrsg.) (1985): Externe Therapie von Hautkrankheiten. Pharmazeutische und medizinische Praxis. Georg Thieme Verlag, Stuttgart New York.

    Google Scholar 

  • Hornstein O.P. (1997): Glukokortikosteroide in der Dermatologie: Tag- und Nacht-Therapie vergessen. Dtsch. Ärztebl. 94: A–678.

    Google Scholar 

  • Hughes B.R., Norris J.F., Cunliffe W.J. (1992): A double-blind evaluation of topical isotretinoin 0,05%, benzoyl peroxide gel 5% and placebo in patients with acne. Clin. Exp. Dermatol. 17:165–168.

    Article  PubMed  CAS  Google Scholar 

  • Jemec G.B.E., Østerlind A. (1994): Cancer in patients treated with coal tar: a long-term follow up study. J. Eur. Acad. Dermatol. Venerol. 3:153–156.

    Article  Google Scholar 

  • Knapp U. (1995): Grundlagen der Wundheilung und Wundbehandlung. Med. Monatsschr. Pharm. 18: 219–230.

    PubMed  CAS  Google Scholar 

  • Korting H.C. (1995): Dermatotherapie: ein Leitfaden. Springer-Verlag, Berlin Heidelberg New York.

    Book  Google Scholar 

  • Korting H.C., Schäfer-Körting M., Klövekorn W., Klövekorn G., Martin C, Laux P. (1995): Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema. Eur. J. Clin. Pharmacol. 48: 461–465.

    Article  PubMed  CAS  Google Scholar 

  • Kragballe K., Barnes L., Hamberg K.J., Hutchinson P., Murphy F., Møller S. et al. (1998): Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br. J. Dermatol. 139: 649–654.

    Article  PubMed  CAS  Google Scholar 

  • Lebwohl M. (1999): The role of salicylic acid in the treatment of psoriasis. Int. J. Dermatol. 38: 16–24.

    Article  PubMed  CAS  Google Scholar 

  • Lemmer B., Brune K. (Hrsg.) (2001): Fülgraff Palm Pharmakotherapie, klinische Pharmakologie, 11. Aufl. Urban & Fischer, München, Jena.

    Google Scholar 

  • Leung D.Y.M. (2001): Atopic dermatitis and the immune system: The role of super-antigens and bacteria. J. Am. Acad. Dermatol. 45: S13–S16.

    Article  PubMed  CAS  Google Scholar 

  • Leyden J.J., Hickman J.G., Jarratt M.T., Stewart D.M., Levy S.F. (2001): The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. J. Cutan. Med. Surg. 5: 37–42.

    PubMed  CAS  Google Scholar 

  • Løkkevik E., Skovlund E., Reitan J.B., Hannisdal E., Tanum G. (1996): Skin treatment with Bepanthen cream versus no cream during radiotherapy. Acta Oncol. 35: 1021–1026.

    Article  PubMed  Google Scholar 

  • Lookingbill D.P., Chalker D.K., Lindholm J.S., Katz H.I., Kempers S.E., Huerter C.J., Swinehart J.M., Schelling D.J., Klauda H.C. (1997): Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J. Am. Acad. Dermatol. 37: 590–595.

    Article  PubMed  CAS  Google Scholar 

  • Lunan H.N. (1975): Topical treatment of the burn patient. Am. J. Hosp. Pharm. 32: 599–605.

    PubMed  CAS  Google Scholar 

  • Maddin S. (Hrsg.) (1991): Current Dermatologic Therapy, 2nd ed. W.B. Saunders Comp., Philadelphia.

    Google Scholar 

  • Maiche A.G., Gröhn P., Mäki-Hokkonen H. (1991): Effect of chamomille cream and almond ointment on acute radiation skin reaction. Acta Oncol. 30: 395–396.

    Article  PubMed  CAS  Google Scholar 

  • Merk H.F., Bickers D.R. (1992): Dermatopharmakologie und Dermatotherapie. Blackwell, Berlin.

    Google Scholar 

  • Molin L. and the Calcipotriol-UVB Study Group (1999): Topical calcipotriol combined with phototherapy for psoriasis. The results of two randomized trials and a review of the literature. Dermatol. 198: 375–381.

    Article  CAS  Google Scholar 

  • Murdoch D., Clissold S.P. (1992): Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs 43: 415–429.

    Article  PubMed  CAS  Google Scholar 

  • Mutschler E., Geisslinger G., Kroemer H.K., Schäfer-Korting M. (2001): Mutschler Arzneimittelwirkungen, 8. Auflage. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart.

    Google Scholar 

  • Nieboer C., de Hoop D., van Loenen A.C., Langendijk P.N.J., van Dijk E. (1989): Systemic therapy with fumaric acid derivatives: New possibilities in the treatment of psoriasis. J. Am. Acad. Dermatol. 20: 601–608.

    Article  PubMed  CAS  Google Scholar 

  • Niedner R. (1998): Kortikoide in der Dermatologie. UNI-MED Verlag, Bremen.

    Google Scholar 

  • Niedner R., Weidhase R., Faude K. (zur Publikation eingereicht) Pyolysin®-Salbe zur Behandlung des Ulcus cruris. Dtsch. Dermatol.

    Google Scholar 

  • Niedner R., Ziegenmeyer J. (Hrsg.) (1992): Dermatika. Therapeutischer Einsatz, Pharmakologie und Pharmazie. Wissenschaftliche Verlagsgesellschaft, Stuttgart.

    Google Scholar 

  • N.N. (1997): Therapie der schweren Psoriasis mit Fumaraten. Arzneimittelbrief 31: 57–59.

    Google Scholar 

  • Nugteren-Huying W.M., van der Schroeff J.G., Hermans J., Suurmond D. (1990): Fumaric acid therapy for psoriasis: A randomized, double-blind, placebo-controlled study. J. Am. Acad. Dermatol. 22: 311–312.

    Article  PubMed  CAS  Google Scholar 

  • Ockenfels H.M., Schultewolter T., Ockenfels G., Funk R., Goos M. (1998): The anti-psoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine work. Br. J. Dermatol. 139: 390–395.

    Article  PubMed  CAS  Google Scholar 

  • Orfanos C.E., Zouboulis C.C., Almond-Roesler B., Geilen C.C. (1997): Current use and future potential role of retinoids in dermatology. Drugs 53: 358–388.

    Article  PubMed  CAS  Google Scholar 

  • Parfitt K. (ed.) (1999): Martindale: The Complete Drug Reference, 32nd edition. Pharmaceutical Press, London.

    Google Scholar 

  • Patel B., Siskin S., Krazmien R., Lebwohl M. (1998): Compatibility of calcipotriene with other topical medications. J. Am. Acad. Dermatol. 38:1010–1011.

    Article  PubMed  CAS  Google Scholar 

  • Peters D.C., Balfour J.A. (1997): Tacalcitol. Drugs 54: 265–271.

    Article  PubMed  CAS  Google Scholar 

  • Petersen E.E., Doerr H.W., Gross G., Petzoldt D., Weissenbacher E.R., Wutzler P. (1999): Der Herpes genitalis. Dtsch. Ärztebl. 96: A-2358–A2364.

    Google Scholar 

  • Pfannschmidt N., Bauer R., Kreysel H.W. (1988): Lokale Kombinationstherapie der Akne mit Erythromycin und Tretinoin. Z. Hautkr. 63: 366–368.

    PubMed  CAS  Google Scholar 

  • Post B., Jänner M. (1971): Indication for tannin therapy in dermatology. Clinical experiences with Tannosynt. Ther. Ggw. 110:1477–1494.

    CAS  Google Scholar 

  • Raab W. (1984): Psoriasis-Behandlung mit Fumarsäure und Fumarsäureestern. Z. Hautkr. 59: 671–679.

    PubMed  CAS  Google Scholar 

  • Raborn G.W., McGaw W.T., Grace M., Eng P., Percy J., Samuels S. (1989): Herpes labialis treatment with acyclovir 5% modified aqueous cream: A double-blind, randomized trial. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 67: 676–679.

    CAS  Google Scholar 

  • Ring J., Fröhlich H.H. (1985): Wirkstoffe in der dermatologischen Therapie, 2. Aufl. Springer-Verlag, Berlin Heidelberg.

    Book  Google Scholar 

  • Ruzicka T., Lorenz B. (1998): Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks’ treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. Br. J. Dermatol. 138: 254–258.

    Article  PubMed  CAS  Google Scholar 

  • Savin J. A. (1985): Some guidelines to the use of topical corticosteroids. Brit. Med. J. 290:1607–1608.

    Article  CAS  Google Scholar 

  • Schäfer-Körting M., Schmid M.H., Korting H.C. (1996): Topical glucocorticoids with improved risk-benefit ratio. Drug Safety 14: 375–385.

    Article  PubMed  Google Scholar 

  • Scharfetter-Kochanek K., Meewes Ch., Eming s., Dissemond J., Hani N., Wenk J., Wlaschenk M., Brenneisen P. (1999): Chronische Wunden und Wachstumsfaktoren. Zeitschr. Hautkrankh. H+G 11: 664–672.

    Google Scholar 

  • Scholz H., Schwabe U. (Hrsg.) (2000): Taschenbuch der Arzneibehandlung - Angewandte Pharmakologie, 12. Aufl. Urban & Fischer, München, Jena.

    Google Scholar 

  • Schulze-Dirks A., Frosch P.J. (1988): Kontaktallergie auf Dexpanthenol. Hautarzt 39: 375–377.

    PubMed  CAS  Google Scholar 

  • Seböck B., Bonnekoh B., Geisel J., Mahrle G. (1994): Antiproliferative and cytotoxic profiles of antipsoriatic fumaric acid derivatives in keratinocyte cultures. Eur. J. Pharmacol. 270: 79–87.

    Google Scholar 

  • Simon C., Stille W. (2000): Antibiotika-Therapie in Klinik und Praxis, 10. Aufl., Schattauer, Stuttgart New York.

    Google Scholar 

  • Stoof T.J., Flier J., Sampar S., Nieboer C., Tensen C.P., Boorsma D.M. (2001): The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells. Br. J. Dermatol. 144:1114–1120.

    Article  PubMed  CAS  Google Scholar 

  • Strömberg H.E., Ågren M.S. (1984): Topical zinc oxide treatment improves arterial and venous leg ulcers. Br. J. Dermatol. 111: 461–468.

    Article  PubMed  Google Scholar 

  • Sykes N.L., Webster G.F. (1994): Acne. A review of optimum treatment. Drugs 48: 59–70.

    Article  PubMed  Google Scholar 

  • Thio H.B., Zomerdijk T.P.L., Oudshoorn C., Kempenaar J., Nibbering P.H., van der Schroeff J.G., Ponec M. (1994): Fumaric acid derivatives evoke a transient increase in intracellular free calcium concentration and inhibit the proliferation of human keratinocytes. Br. J. Dermatol. 131: 856–861.

    Article  PubMed  CAS  Google Scholar 

  • Trauner M.A., Ruben B.S. (1999): Isotretinoin induced rhabdomyolysis? A case report. Dermatol. Online J. 5: 2.

    CAS  Google Scholar 

  • Tronnier H., Haas P.J., Zimmermann T. (1990): Effectiveness and mechanism of action of isoprenaline sulfate and clemastine hydrogen fumarate on histamine wheal-induced pruritus. A placebo-controlled proband study. Derm. Beruf Umwelt 38:15–18.

    PubMed  CAS  Google Scholar 

  • Trozak D.J. (1999): Topical corticosteroid therapy in psoriasis vulgaris: Update and new strategies. Cutis 64: 315–318.

    PubMed  CAS  Google Scholar 

  • Vandermeeren M., Janssens S., Borgers M., Geysen J. (1997): Dimethylfumarate is an inhibitor of cytokine-induced E-selectin, VCAM-1, and ICAM-1 expression in human endothelial cells. Biochem. Biophys. Res. Commun. 234:19–23.

    Article  PubMed  CAS  Google Scholar 

  • Veien N.K., Bjerke J.R., Rossmann-Ringdahl I., Jakobsen H.B. (1997): Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial. Br. J. Dermatol. 137: 581–586.

    Article  PubMed  CAS  Google Scholar 

  • Warnecke J., Wendt A. (1998): Anti-inflammatory action of pale sulfonated shale oile (ICHTHYOL pale) in UVB erythema test. Inflamm. Res. 47: 75–78.

    Article  PubMed  CAS  Google Scholar 

  • Walluf-Blume D. (1991): Aufbereitung und Nachzulassung von OTC-Arzneimitteln in den USA 1990. Pharm. Ind. 53: 152–158.

    Google Scholar 

  • Wiesenauer M. (1987): Homöopathie für Apotheker und Ärzte. Deutscher Apotheker Verlag, Stuttgart.

    Google Scholar 

  • Wolf-Jürgensen P. (1979): Efficacy of bufexamac cream versus betamethasone valerate cream in contact dermatitis: a double-blind trial. Curr. Med. Res. Opin. 5: 779–784.

    Article  PubMed  Google Scholar 

  • Zouboulis C.C., Fluhr J.W. (1999): Akne - Aktuelle Aspekte zu Pathophysiologie und Therapie. Pharm. Ztg. 144: 4223–4231.

    Google Scholar 

Download references

Authors
  1. Uwe Fricke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut der Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg, Germany

    Ulrich Schwabe

  2. Bachstraße 29, 50858, Köln, Germany

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fricke, U. (2001). Dermatika und Wundbehandlungsmittel. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2001. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56434-5_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56434-5_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42079-8

  • Online ISBN: 978-3-642-56434-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation